Member Info for Laura2022

See the sunmariesnfrom RocketV1 and myself

All info and opportunities are there

Will be hard to buy soon

They will take 15mln now

Even if you accept the highly likely scenario that on the 12th Aigust GM CEO and his backers who own 70% will get the vote to de list there is still a chance to gain from a purchase at 2.6p

1) look at DEST and CGG who both have done 100-200% after the GM confirmation

2) SND shares will be worth alot more than 2.6p as a private company ..possibly even I'm time applying to the USA growth market or main NASDAQ

The backers of the Ceo called ROX have bankrolled SND at 10 pence and the market share is large for SND offering

two smaller ASIC projects achieved 'tape out' status during the year, one of which led to Sondrel's first production order in late 2023. The first production revenues are anticipated in the second half of 2024 as a result. In addition, a significant new ASIC project was won in early 2024 for a next generation video processing chip with a total estimated value of US$23 million across the design, qualification and projected production life of the product.

The ASIC Market

The market for ASIC design remains one with significant opportunity for Sondrel particularly in the growing AI market, and is extremely dynamic and evolving:

Market Size and Growth Trends

The ASIC chip market was valued at an estimated USD 20.29 billion in 2024 and is projected to reach USD 32.84 billion by 2031, growing at a CAGR of 7.10% during this period (Source: ASIC Chip Market Size & Share Analysis - Industry Research Report - Growth Trends (coherentmarketinsights.com).

Factors driving growth include the adoption of advanced technologies such as AI, machine learning, and 5G, and these all increase demand for ASICs across industries.

Meeting will be confirmed BUT there will be fireworks

Won't drop from here

Partic as SND like CGH got an even smaller shares left to buy, I started buying Friday 2.6-2.7

See my summary on SND

I was right about CGH and DEST

I expect SND to do more

Not sure soulac

One to watch

Suzy gone

As for the other comments , really pathetic, on the SAR forum and VAL I have been falsely accused of being 4 different people!

Many on these BBs are really sad individuals

Hitesh is expert in this field and also one of main consultants to PYC

From early 2023 article published in Frontiers Mag

Project Optimus has relevance to Physiomics both in its core consulting business and its personalised oncology initiatives. In core consulting, Project Optimus encourages and some would say even mandates biotech and pharma companies to fully utilise all available non-clinical and clinical data to make informed decisions about clinical trial design and biologically effective dose. The Company believes that there is an increasing expectation that companies meeting with the FDA should have utilised mathematical modelling in support of clinical trial design and dosing decision making. The Company has first hand experience of this through the translational modelling work it has completed for multiple small and medium sized clients in recent years.

 

Looking beyond drug development, the Company sees a clear implication of Project Optimus on dosing of approved drugs in cancer. The vast majority of cancer drugs are still approved on a "one size fits all" basis with, at most, adjustments in dosing being made to account for body weight or surface area of individual patients. The Company believes that the future direction of cancer drug dosing will take into account its effect in each individual and we believe that our personalised dosing tool is a clear step towards achieving that goa

Great information

Of course he doesn't

He's a complete troll and malicious person as his 2yr posting susmmrt shows

Fantastic thanks Debull

"revenues are falling even further"

Just hit record ever contracted revenues for a calander year and already booked £500k in first month of 2024/25

Go away

Don't bring your sully spat over from VAL

You've accused me of being 4 different people lol

Recently "Seawolf" k here

As for lifestyle business..GDR wasted £4mln a year amd CEO was on £350k for hugely loss making company, PYC CEO has done x 3 GDR revenues on a 3rd of his salary

Nice one whining swine

Looks like PYC are absolutely in the right space at the right time with PROVEN track record and client list satisfaction

Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic DiseasesGuidance for Industry; AvailabilityAUGUST 2024

PYC are exactly this for those new to PYC Hitesh is a PYC consultant

His words:

"Oncology PKPD modellers should be in insanely high demand now this is out